Dividend Investing Ideas Center
Critical Facts You Need to Know About Preferred Stocks
Have you ever wished for the safety of bonds, but the return potential...
Name
As of 12/06/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
YTD Return
6.6%
1 yr return
10.6%
3 Yr Avg Return
4.9%
5 Yr Avg Return
7.1%
Net Assets
$11.8 M
Holdings in Top 10
44.8%
Expense Ratio 2.35%
Front Load N/A
Deferred Load N/A
Turnover 19.00%
Redemption Fee N/A
Standard (Taxable)
$250
IRA
N/A
Fund Type
Open End Mutual Fund
Name
As of 12/06/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
The Portfolio will normally invest at least 80% of its total assets in equity securities of U.S. and foreign healthcare companies and biotechnology companies, regardless of their stock market value (or “market capitalization”). Equity securities include common stocks, preferred stocks, securities convertible into common stocks and warrants. The Adviser utilizes a top-down investment approach focused on long-term economic trends. The Adviser begins with the overall outlook for the economy, then seeks to identify specific industries with attractive characteristics and long-term growth potential. Ultimately, the Adviser seeks to identify high-quality companies within the selected industries and to acquire them at attractive prices. The Adviser’s stock selection process is based on an analysis of individual companies’ fundamental values, such as earnings growth potential and the quality of corporate management.
Companies described as Health Care Equipment and Supplies, Health Care Provider Services, Pharmaceutical or Biotechnology Companies under the North American Industry Classification System are considered healthcare or biotechnology companies for purposes of investment by the Portfolio. These companies are principally engaged in: the design, manufacture or sale of products or services used for or in connection with health, medical, or personal care such as medical, dental and optical supplies or equipment; research and development of pharmaceutical products and services; the operation of healthcare facilities such as hospitals, clinical test laboratories and convalescent and mental healthcare facilities; and the design, manufacture, or sale of healthcare-related products and services, research, development, manufacture or distribution of products and services relating to human health care, pharmaceuticals, agricultural and veterinary applications and the environment; and manufacturing and/or distributing biotechnological and biomedical products, devices or instruments or provide materials, products or services to the foregoing companies.
Factors considered include growth potential, earnings, valuation, competitive advantages and management. When market or financial conditions warrant, the Portfolio may also make temporary investments in investment grade debt securities. Such investment strategies could result in the Portfolio not achieving its investment objective.
Period | SBHIX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 6.6% | -19.4% | 22.6% | 63.52% |
1 Yr | 10.6% | -7.9% | 34.9% | 81.13% |
3 Yr | 4.9%* | -25.3% | 12.3% | 28.95% |
5 Yr | 7.1%* | -8.3% | 12.9% | 48.63% |
10 Yr | 5.9%* | -0.2% | 12.7% | 72.07% |
* Annualized
Period | SBHIX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | -4.4% | -12.6% | 19.0% | 89.94% |
2022 | -2.7% | -53.9% | 3.2% | 3.29% |
2021 | 13.3% | -39.6% | 24.2% | 13.16% |
2020 | -7.4% | -13.6% | 178.2% | 98.66% |
2019 | 12.2% | 3.8% | 63.8% | 92.48% |
Period | SBHIX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 6.6% | -19.4% | 22.6% | 63.52% |
1 Yr | 10.6% | -7.9% | 34.9% | 81.13% |
3 Yr | 4.9%* | -25.3% | 12.3% | 28.95% |
5 Yr | 7.1%* | -8.3% | 12.9% | 48.63% |
10 Yr | 5.9%* | -0.2% | 12.7% | 72.07% |
* Annualized
Period | SBHIX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 0.0% | -12.6% | 19.0% | 82.39% |
2022 | 2.4% | -53.9% | 3.7% | 2.63% |
2021 | 17.2% | -33.9% | 26.0% | 19.08% |
2020 | 4.0% | -0.7% | 180.6% | 97.32% |
2019 | 21.1% | 4.6% | 63.8% | 83.46% |
SBHIX | Category Low | Category High | SBHIX % Rank | |
---|---|---|---|---|
Net Assets | 11.8 M | 6.66 M | 45.7 B | 87.42% |
Number of Holdings | 34 | 25 | 430 | 92.45% |
Net Assets in Top 10 | 5.9 M | 2.12 M | 23.9 B | 85.53% |
Weighting of Top 10 | 44.80% | 18.4% | 78.1% | 57.86% |
Weighting | Return Low | Return High | SBHIX % Rank | |
---|---|---|---|---|
Stocks | 97.47% | 89.92% | 106.13% | 59.75% |
Cash | 2.60% | 0.00% | 33.01% | 45.91% |
Preferred Stocks | 0.00% | 0.00% | 7.86% | 54.09% |
Other | 0.00% | -22.99% | 23.24% | 53.46% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 35.06% |
Bonds | 0.00% | 0.00% | 12.39% | 50.94% |
Weighting | Return Low | Return High | SBHIX % Rank | |
---|---|---|---|---|
Healthcare | 100.00% | 59.26% | 100.00% | 17.53% |
Utilities | 0.00% | 0.00% | 0.00% | 28.57% |
Technology | 0.00% | 0.00% | 22.69% | 34.42% |
Real Estate | 0.00% | 0.00% | 5.89% | 32.47% |
Industrials | 0.00% | 0.00% | 7.02% | 33.77% |
Financial Services | 0.00% | 0.00% | 1.60% | 50.00% |
Energy | 0.00% | 0.00% | 0.00% | 28.57% |
Communication Services | 0.00% | 0.00% | 9.11% | 31.82% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 36.36% |
Consumer Cyclical | 0.00% | 0.00% | 1.92% | 33.77% |
Basic Materials | 0.00% | 0.00% | 7.16% | 53.90% |
Weighting | Return Low | Return High | SBHIX % Rank | |
---|---|---|---|---|
US | 97.47% | 61.27% | 104.41% | 28.93% |
Non US | 0.00% | 0.00% | 34.10% | 76.73% |
SBHIX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 2.35% | 0.08% | 4.48% | 13.21% |
Management Fee | 1.25% | 0.03% | 1.25% | 98.74% |
12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
Administrative Fee | N/A | 0.03% | 0.25% | 60.00% |
SBHIX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 3.50% | 5.75% | N/A |
Deferred Load | N/A | 1.00% | 1.00% | N/A |
SBHIX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 1.00% | 16.67% |
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
SBHIX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 19.00% | 0.00% | 238.00% | 12.59% |
SBHIX | Category Low | Category High | SBHIX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 6.24% | 55.35% |
SBHIX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | None | Annual | Quarterly | Annual |
SBHIX | Category Low | Category High | SBHIX % Rank | |
---|---|---|---|---|
Net Income Ratio | -0.69% | -2.54% | 1.85% | 80.26% |
SBHIX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
Date | Amount | Type |
---|---|---|
Dec 08, 2023 | $1.020 | CapitalGainLongTerm |
Dec 09, 2022 | $1.275 | CapitalGainLongTerm |
Dec 10, 2021 | $0.092 | CapitalGainShortTerm |
Dec 10, 2021 | $0.696 | CapitalGainLongTerm |
Dec 11, 2020 | $2.579 | OrdinaryDividend |
Dec 11, 2019 | $0.908 | OrdinaryDividend |
Dec 11, 2019 | $0.908 | CapitalGainLongTerm |
Dec 12, 2018 | $4.061 | CapitalGainLongTerm |
Dec 14, 2017 | $4.235 | CapitalGainLongTerm |
Dec 19, 2016 | $3.112 | CapitalGainLongTerm |
Dec 21, 2015 | $3.051 | CapitalGainLongTerm |
Dec 19, 2014 | $2.719 | CapitalGainLongTerm |
Dec 19, 2013 | $1.582 | CapitalGainLongTerm |
Start Date
Tenure
Tenure Rank
Jan 18, 2019
3.37
3.4%
Robert D. Stimpson, CFA, CMT. Mr. Stimpson is Co-Chief Investment Officer and a Portfolio Manager at Oak Associates, which he joined in 2001. Prior to joining Oak Associates in 2001, Mr. Stimpson earned an MBA from Emory University. Previously, Mr. Stimpson worked as an Equity Market Analyst for I.D.E.A., ltd and for Merrill Lynch as a Financial Consultant. He has been with the investment industry since 1997. In addition to the CFA designation, Mr. Stimpson holds the CMT charter from the Market Technicians Association.
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.02 | 24.72 | 7.88 | 0.25 |
Dividend Investing Ideas Center
Have you ever wished for the safety of bonds, but the return potential...
Dividend Investing Ideas Center
If you are reaching retirement age, there is a good chance that you...
Dividend Investing Ideas Center
If you are reaching retirement age, there is a good chance that you...